急性缺血性脑卒中患者溶栓治疗结合绿色通道构建的临床探讨

The clinical effect of thrombolysis combined treatment Easy Access construction in patients with acute ischemic stroke

目的:探讨急性溶栓治疗结合绿色通道的构建对急性缺血性脑卒中患者治疗效果的影响。方法:以300例接受绿色通道溶栓治疗的急性缺血性脑卒中患者为研究组,以传统的急救流程的300例急性缺血性脑卒中患者为对照组。比较两组溶栓时间、溶栓率,病死率、临床治疗效果的差异。结果:研究组自就诊到接受溶栓治疗的时间为(68.2±9.7)min,显著低于对照组的(155.5±17.2)min(P<0.01);研究组的溶栓成功17例(5.7%)显著高于对照组2例(0.7%)。研究组基本痊愈120例(40%)、显著进步113例(37.7%)、进步53例(17.7%),显著高于对照组55例(18.3%)、52例(17.3%)、66例(22%);无变化及恶化例数分别为10例(3.3%)、3例(1%)均显著低于对照组68例(22.7%)、47例(15.7%),(P<0.05)。研究组病死率0.3%(1例)显著低于对照组4%(12例),(P<0.05)。结论:绿色通道的构建能有效缩短急性缺血性脑卒中患者自就诊到接受溶栓治疗的时间,提高溶栓率及临床治疗效果,降低病死率,值得进一步在临床推广。

Objective To investigate t The clinical effect of thrombolysis combined treatment Easy Access construction in patients with acute ischemic stroke. Method 300 patients received the acute ischemic stroke patients Easy Access thrombolytic as research group,300 cases of patients with acute ischemic stroke of traditional emergency procedures for the control group. Compared the thrombolytic time,thrombolytic rate,mortality rate,clinical therapeutic effect of the two groups. Results The time of study group from treatment to receive thrombolytic therapy was（ 68. 2 ± 9. 7） min,which was significantly lower than the control group of（ 155. 5 ± 17. 2） min（ P〈0. 01）; Case of successful hrombolysis on study group was 17 cases（ 5. 7%）,which was significantly higher than that in the control group of 2 cases（ 0. 7%）. The research group were cured 120 cases（ 40%）,significant progress in 113 cases（ 37. 7%）,improved in 53 cases（ 17. 7%）,significantly higher than the control group of 55 cases（ 18. 3%）,52 cases（ 17. 3%）,66 cases（ 22%）; no changes and deterioration of cases were 10 cases（ 3. 3%）,3 cases（ 1%） were significantly lower than the control group of 68 cases（ 22. 7%）,47 cases（ 15. 7%）（ P〈0. 05）. The mortality rate of study group was 0. 3%（ 1 cases） was significantly lower than the control group 4%（ 12 cases）（ P〈0. 05）. Conclusion Easy Access construction can effectively shorten the acute ischemic stroke patients from the clinic to receive thrombolytic therapy time,improve the thrombolytic rate and clinical curative effect,reduce the mortality rate,and is worthy of further promotion in clinical.